FLGT News and Press, Fulgent Genetics Inc. From 02/07/22

Shares of Fulgent Genetics (NASDAQ: FLGT) sank 36.5% amid turbulent trading for the broader market in January, according to data from S&P Global Market Intelligence . Both the S&P 500 and the Nasdaq Composite indexes entered into correction territory amid mountin...

Before the pandemic, Fulgent Genetics (NASDAQ: FLGT) was a little-known genetic testing business with grand ambitions but limited means. Since January of 2020, its stock has provided the not-too-shabby return of 385%. Now, with more than $1 billion in trailing 12-month revenue d...

Shares of diagnostic testing company Fulgent Genetics (NASDAQ: FLGT) were up 93% last year, according to S&P Global Market Intelligence . The unpredictability of COVID took shareholders on a journey through several peaks and valleys on the way to that gain. The roller co...

The market's a forward-looking mechanism, and some people might feel that the COVID-19 pandemic is "over." That's probably an exaggeration. While vaccinations will hopefully reduce the danger, the virus will continue to mutate, and healthcare companies will continue to fight it. Read more t...

Valuation measures like the price-to-earnings (P/E) ratio can be effective tools for investors to use in assessing stocks and comparing their relative attractiveness. Currently, the S&P 500 's P/E ratio stands at more than 30, which is steep compared to years past when it was far lo...

The 7-day moving average for daily COVID-19 cases reached 240,408, a level not seen since January when the country was in the throes of the Delta variant. CDC data shows that the 7-day moving average peaked on Jan. 11 with 250,437 cases. Given recent trends, it is likely that figure will be s...

Investing in the healthcare space can be a volatile endeavor, especially with smaller, younger businesses. Fortunately, there are two companies that have some tailwinds to help provide stability while bringing more and more products to the market. Moderna (NASDAQ: MRNA) and ...

The FDA says that early data indicates that antigen tests for COVID are able to detect the Omicron variant, but may have reduced sensitivity. Sensitivity is the term used to describe the accuracy of a test in the form of the true positive rate. If a test has lower sensitivity, it means that f...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Changing the rules The Centers for Disease Control and Prevention is updating recommendations for COVID-19 control, shortening isolation restrictions from ...

In a meeting with some of the nation's governors, President Biden pledged to support states struggling with the Omicron variant, but acknowledged that they will need to take the lead in controlling the pandemic. Arkansas Governor Asa Hutchinson, who is chair of the National Governors Associat...